In multiple cross-sectional studies of adults and children with NAFLD, serum NRG4 levels were significantly lower when compared to healthy controls, suggesting an important role of NRG4 in human NALFD as well (96–98). The gene discussed is NRG4; the disease is metabolic dysfunction-associated steatotic liver disease.